Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Acquisitions & Divestments (2018 - 2025)

Neurogene (NGNE) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $99.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 1037.14% year-over-year to $99.5 million, compared with a TTM value of $228.0 million through Sep 2025, up 291.33%, and an annual FY2024 reading of $74.0 million, up 1380.0% over the prior year.
  • Change in Acquisitions & Divestments was $99.5 million for Q3 2025 at Neurogene, up from $68.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $99.5 million in Q3 2025 and bottomed at $8.8 million in Q3 2024.